PAMP
HUMA icon

Polar Asset Management Partners’s Humacyte HUMA Stock Holding History

Polar Asset Management Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500,000
Closed -$853K – 651
2025
Q1 		$853K Buy
+500,000
New +$1.88M 0.02% 317

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Polar Asset Management Partners's HUMA Position: Q2 2025 in Review

Polar Asset Management Partners sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 500,000 shares — an estimated $853K sold.

Polar Asset Management Partners first reported a position in HUMA in Q1 2025 and held it in 1 quarter. The position peaked at $853K in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Polar Asset Management Partners reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 500,000 Humacyte shares in Q2 2025, an estimated $853K.
  • Polar Asset Management Partners first reported a position in Humacyte in Q1 2025 and held it in 1 quarter.
  • Polar Asset Management Partners's Humacyte position peaked at $853K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.